Aptahem AB (XSAT:APTA) Accounts Payable : kr0.86 Mil (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Aptahem AB Accounts Payable?

Aptahem AB's Accounts Payable for the quarter that ended in Dec. 2024 was kr0.86 Mil.

Aptahem AB's quarterly Accounts Payable increased from Jun. 2024 (kr0.86 Mil) to Sep. 2024 (kr1.42 Mil) but then declined from Sep. 2024 (kr1.42 Mil) to Dec. 2024 (kr0.86 Mil).

Aptahem AB's annual Accounts Payable declined from Dec. 2022 (kr3.70 Mil) to Dec. 2023 (kr0.97 Mil) and declined from Dec. 2023 (kr0.97 Mil) to Dec. 2024 (kr0.86 Mil).

Aptahem AB Accounts Payable Historical Data

The historical data trend for Aptahem AB's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptahem AB Accounts Payable Chart

Aptahem AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable

Get a 7-Day Free Trial

3.14

0.94

3.70

0.97

0.86

Aptahem AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Accounts Payable	Get a 7-Day Free Trial															0.97	0.86	0.86	1.42	0.86

Aptahem AB Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Aptahem AB Accounts Payable Related Terms

Thank you for viewing the detailed overview of Aptahem AB's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptahem AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptahem AB (XSAT:APTA) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Norra Vallgatan 58, Malmo, SWE, 211 22

Website

http://www.aptahem.com

Aptahem AB develops aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company's main candidate Apta-1 is developed as an emergency medicine intended to prevent the occurrence of life-threatening organ and tissue damage in patients suffering from sepsis.

Aptahem AB Headlines

No Headlines